171 related articles for article (PubMed ID: 37570507)
1. Role of Chemical Reduction and Formulation of Graphene Oxide on Its Cytotoxicity towards Human Epithelial Bronchial Cells.
Pelin M; Passerino C; Rodríguez-Garraus A; Carlin M; Sosa S; Suhonen S; Vales G; Alonso B; Zurutuza A; Catalán J; Tubaro A
Nanomaterials (Basel); 2023 Jul; 13(15):. PubMed ID: 37570507
[TBL] [Abstract][Full Text] [Related]
2. Impact of physico-chemical properties on the toxicological potential of reduced graphene oxide in human bronchial epithelial cells.
Rodríguez-Garraus A; Passerino C; Vales G; Carlin M; Suhonen S; Tubaro A; Gómez J; Pelin M; Catalán J
Nanotoxicology; 2023 Jun; 17(5):471-495. PubMed ID: 37799028
[TBL] [Abstract][Full Text] [Related]
3. No cytotoxicity or genotoxicity of graphene and graphene oxide in murine lung epithelial FE1 cells in vitro.
Bengtson S; Kling K; Madsen AM; Noergaard AW; Jacobsen NR; Clausen PA; Alonso B; Pesquera A; Zurutuza A; Ramos R; Okuno H; Dijon J; Wallin H; Vogel U
Environ Mol Mutagen; 2016 Jul; 57(6):469-82. PubMed ID: 27189646
[TBL] [Abstract][Full Text] [Related]
4. An in vitro evaluation of graphene oxide reduced by Ganoderma spp. in human breast cancer cells (MDA-MB-231).
Gurunathan S; Han J; Park JH; Kim JH
Int J Nanomedicine; 2014; 9():1783-97. PubMed ID: 24741313
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress-mediated antibacterial activity of graphene oxide and reduced graphene oxide in Pseudomonas aeruginosa.
Gurunathan S; Han JW; Dayem AA; Eppakayala V; Kim JH
Int J Nanomedicine; 2012; 7():5901-14. PubMed ID: 23226696
[TBL] [Abstract][Full Text] [Related]
6. Intracellular localization and toxicity of graphene oxide and reduced graphene oxide nanoplatelets to mussel hemocytes in vitro.
Katsumiti A; Tomovska R; Cajaraville MP
Aquat Toxicol; 2017 Jul; 188():138-147. PubMed ID: 28521151
[TBL] [Abstract][Full Text] [Related]
7. Internalization and cytotoxicity of graphene oxide and carboxyl graphene nanoplatelets in the human hepatocellular carcinoma cell line Hep G2.
Lammel T; Boisseaux P; Fernández-Cruz ML; Navas JM
Part Fibre Toxicol; 2013 Jul; 10():27. PubMed ID: 23849434
[TBL] [Abstract][Full Text] [Related]
8. Reduction of graphene oxide by resveratrol: a novel and simple biological method for the synthesis of an effective anticancer nanotherapeutic molecule.
Gurunathan S; Han JW; Kim ES; Park JH; Kim JH
Int J Nanomedicine; 2015; 10():2951-69. PubMed ID: 25931821
[TBL] [Abstract][Full Text] [Related]
9. Green synthesis of graphene and its cytotoxic effects in human breast cancer cells.
Gurunathan S; Han JW; Eppakayala V; Kim JH
Int J Nanomedicine; 2013; 8():1015-27. PubMed ID: 23687445
[TBL] [Abstract][Full Text] [Related]
10.
Cebadero-Domínguez O; Ferrández-Gómez B; Sánchez-Ballester S; Moreno J; Jos A; Cameán AM
Toxicol Rep; 2022; 9():1130-1138. PubMed ID: 36518447
[TBL] [Abstract][Full Text] [Related]
11. rGO outperforms GO in generating oxidative stress and DNA strand breaks in zebrafish liver cells.
Siqueira PR; Souza JP; Venturini FP; Carmo TLL; Azevedo VC; Estevão BM; Bonomo MM; Santos FA; Zucolotto V; Fernandes MN
Aquat Toxicol; 2023 Sep; 262():106640. PubMed ID: 37595501
[TBL] [Abstract][Full Text] [Related]
12. Concentration- and time-dependence toxicity of graphene oxide (GO) and reduced graphene oxide (rGO) nanosheets upon zebrafish liver cell line.
Siqueira PR; Souza JP; Estevão BM; Altei WF; Carmo TLL; Santos FA; Araújo HSS; Zucolotto V; Fernandes MN
Aquat Toxicol; 2022 Jul; 248():106199. PubMed ID: 35613511
[TBL] [Abstract][Full Text] [Related]
13. A transcriptomic overview of lung and liver changes one day after pulmonary exposure to graphene and graphene oxide.
Poulsen SS; Bengtson S; Williams A; Jacobsen NR; Troelsen JT; Halappanavar S; Vogel U
Toxicol Appl Pharmacol; 2021 Jan; 410():115343. PubMed ID: 33227293
[TBL] [Abstract][Full Text] [Related]
14. Genotoxicity evaluation of graphene derivatives by a battery of in vitro assays.
Cebadero-Dominguez Ó; Medrano-Padial C; Puerto M; Sánchez-Ballester S; Cameán AM; Jos Á
Chem Biol Interact; 2023 Feb; 372():110367. PubMed ID: 36706891
[TBL] [Abstract][Full Text] [Related]
15. A systems toxicology approach to the surface functionality control of graphene-cell interactions.
Chatterjee N; Eom HJ; Choi J
Biomaterials; 2014 Jan; 35(4):1109-27. PubMed ID: 24211078
[TBL] [Abstract][Full Text] [Related]
16. Oxygen content-related DNA damage of graphene oxide on human retinal pigment epithelium cells.
Ou L; Lv X; Wu Z; Xia W; Huang Y; Chen L; Sun W; Qi Y; Yang M; Qi L
J Mater Sci Mater Med; 2021 Feb; 32(2):20. PubMed ID: 33638700
[TBL] [Abstract][Full Text] [Related]
17. Graphene oxide and reduced graphene oxide induced neural pheochromocytoma-derived PC12 cell lines apoptosis and cell cycle alterations via the ERK signaling pathways.
Kang Y; Liu J; Wu J; Yin Q; Liang H; Chen A; Shao L
Int J Nanomedicine; 2017; 12():5501-5510. PubMed ID: 28814866
[TBL] [Abstract][Full Text] [Related]
18. Graphene Oxide and Reduced Graphene Oxide Exhibit Cardiotoxicity Through the Regulation of Lipid Peroxidation, Oxidative Stress, and Mitochondrial Dysfunction.
Zhang J; Cao HY; Wang JQ; Wu GD; Wang L
Front Cell Dev Biol; 2021; 9():616888. PubMed ID: 33816465
[TBL] [Abstract][Full Text] [Related]
19. Graphene and graphene oxide induce ROS production in human HaCaT skin keratinocytes: the role of xanthine oxidase and NADH dehydrogenase.
Pelin M; Fusco L; Martín C; Sosa S; Frontiñán-Rubio J; González-Domínguez JM; Durán-Prado M; Vázquez E; Prato M; Tubaro A
Nanoscale; 2018 Jul; 10(25):11820-11830. PubMed ID: 29920573
[TBL] [Abstract][Full Text] [Related]
20. Ginkgo biloba: a natural reducing agent for the synthesis of cytocompatible graphene.
Gurunathan S; Han JW; Park JH; Eppakayala V; Kim JH
Int J Nanomedicine; 2014; 9():363-77. PubMed ID: 24453487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
